<?xml version="1.0" encoding="UTF-8"?>
<abstract abstract-type="author-highlights" id="abs0020">
 <title>Highlights</title>
 <p>
  <list list-type="simple" id="ulist0010">
   <list-item id="u0010">
    <label>•</label>
    <p id="p0010">The current investigation of small molecule drugs as promising medicine for COVID-19 is discussed.</p>
   </list-item>
   <list-item id="u0015">
    <label>•</label>
    <p id="p0015">Examination and comparative analysis of the physicochemical descriptors of approved and experimental drugs selected for COVID-19 treatment could be useful for antiviral drug optimization, drug combination tactic.</p>
   </list-item>
   <list-item id="u0020">
    <label>•</label>
    <p id="p0020">Among 14 selected potential drugs based on small heterocyclic molecules, no molecule is “ideal” according to the Lipinski-Veber rules and bioactivity scores.</p>
   </list-item>
   <list-item id="u0025">
    <label>•</label>
    <p id="p0025">Drug combination based on a hybridization concept could be a useful and efficient approach in the creation of an antiviral molecule hybrid drug against SARS-CoV-2.</p>
   </list-item>
  </list>
 </p>
</abstract>
